This inventor holds 8 USPTO granted patents. Top assignees: The General Hospital Corporation, Bristol-Myers Squibb Compnay, Northeastern University. Active years: 1983-1999.
Company Filing History:



Years Active: 1983-1999
Title: Ban A Khaw: Innovator in Immunology
Introduction
Ban A Khaw is a notable inventor based in Milton, MA (US), recognized for his contributions to immunology. He holds a total of 8 patents, showcasing his innovative approach to medical science and technology.
Latest Patents
His latest patents include significant advancements in the field of immunology. One of his notable inventions is a method for inducing tolerance to T-cell mediated immunity. This method is particularly aimed at inducing tolerance in a recipient mammal to a transplanted organ or tissue. Tolerance is achieved by treating the recipient with a modified MHC antigen that has an immunosuppressive effect. Another important patent involves methods for salvaging a target cell from cell death. This invention comprises contacting a target cell with a specific affinity reagent-liposome conjugate to prevent cell death due to membrane disruption. Additionally, it discloses methods for delivering a selected agent into a damaged target cell for diagnosis and therapy.
Career Highlights
Throughout his career, Ban A Khaw has made significant strides in the medical field. He has worked with reputable institutions, including The General Hospital Corporation and Massachusetts General Hospital Corporation. His work has had a profound impact on the understanding and treatment of various medical conditions.
Collaborations
Ban A Khaw has collaborated with esteemed colleagues such as H William Strauss and Edgar Haber. These collaborations have further enriched his research and innovations in immunology.
Conclusion
Ban A Khaw's contributions to immunology through his patents and collaborations highlight his role as a leading inventor in the field. His innovative methods and dedication to advancing medical science continue to influence the industry.